Author

Liaqat Ali

New York University Abu Dhabi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Loganathan PalanikumariD· 2 shared Mazin M. MagzoubiD· 2 shared Amani Al NuairiiD· 1 shared Christopher BreunigiD· 1 shared Colin Campbell· 1 shared Esha Sadiq· 1 shared Faten Mansoor Yasin· 1 shared Francisco N. BarreraiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Loganathan PalanikumarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nuclear βactin dependent chromatin accessibility governs stem cell pluripotency and extracellular matrix gene programs to maintain cellular biomechanics for cell lineage decisions

Colin Campbell, Nadine Hosny El Said, Amani Al Nuairi, Loganathan Palanikumar, Christopher Breunig, Muhammedin Deliorman, Zahraa Alraies, Esha Sadiq, Sabrina C. Desbordes, Liaqat Ali, Muhammad Shiraz Ali, Giuseppe Saldi, Martin J. Lohse, Mazin M. Magzoub, Mohammad Ameen Qasaimeh, Piergiorgio Percipalle

This study shows nuclear βactin regulates chromatin accessibility and ECM mechanics to maintain pluripotency and lineage decisions in mESCs.

bioRxiv · Sep 10, 2026 · PreprintCell Biology

Tumor-targeted hydroxyapatite nanoparticles for dual-mode diagnostic imaging and near-infrared light-triggered photothermal cancer therapy

Loganathan Palanikumar, Faten Mansoor Yasin, Itgel Munkhjargal, Maylis Boitet, Liaqat Ali, Mohamed E.M. Ali, Rainer Straubinger, Francisco N. Barrera, Mazin M. Magzoub

This paper develops tumor-targeted hydroxyapatite nanoparticles for dual-mode imaging and photothermal cancer therapy, showing effective tumor targeting and prolonged survival in vivo.

bioRxiv · Feb 20, 2025 · PreprintBioengineering